Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabine Riethdorf

Showing results (51-60 of 172) with videos related to

Pageof 18
Sort By:
International Journal of Cancer|September 27, 2016
A nonrandomized, prospective, clinical study on the impact of circulating tumor cells on outcomes of urothelial carcinoma of the bladder patients treated with radical cystectomy with or without adjuvant chemotherapyArmin Soave, Sabine Riethdorf, Roland Dahlem, et al.
Journal for Immunotherapy of Cancer|June 16, 2023
First-line treatment of unresectable or metastatic HER2 positive esophagogastric adenocarcinoma: liquid biomarker analysis of the phase 2 INTEGA trialLisa Paschold, Alexander Stein, Benjamin Thiele, et al.
World Journal of Urology|April 24, 2024
Limited prognostic role of routine serum markers (AP, CEA, LDH and NSE) in oligorecurrent prostate cancer patients undergoing PSMA-radioguided surgeryGisa Mehring, Christina Steinbach, Randi Pose, et al.
BJU International|August 26, 2010
Detection of circulating tumour cells in peripheral blood of patients with advanced non-metastatic bladder cancerMichael Rink, Felix K H Chun, Sarah Minner, et al.
Breast Cancer Research : BCR|August 17, 2012
Prognostic impact of circulating tumor cells assessed with the CellSearch System™ and AdnaTest Breast™ in metastatic breast cancer patients: the DETECT studyVolkmar Müller, Sabine Riethdorf, Brigitte Rack, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
Rare expression of epithelial cell adhesion molecule on residual micrometastatic breast cancer cells after adjuvant chemotherapyHolger Thurm, Sebastian Ebel, Christina Kentenich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
Expression of extracellular matrix metalloproteases inducer on micrometastatic and primary mammary carcinoma cellsNatalie Reimers, Kristine Zafrakas, Volker Assmann, et al.
Molecular Oncology|April 24, 2026
Circulating tumor cell viability during and after radiotherapy mirrors treatment response in cancer patientsYvonne Goy, Jana Löptien, Cornelia Coith, et al.
Molecular Oncology|August 6, 2016
Frequent detection of PIK3CA mutations in single circulating tumor cells of patients suffering from HER2-negative metastatic breast cancerChristin Gasch, Theresa Oldopp, Oliver Mauermann, et al.
Clinical Chemistry|May 23, 2013
Capture of viable circulating tumor cells in the liver of colorectal cancer patientsEric Denève, Sabine Riethdorf, Jeanne Ramos, et al.
Pageof 18

Showing results (51-60 of 172) with videos related to

Sort By:
Pageof 18
International Journal of Cancer|September 27, 2016
A nonrandomized, prospective, clinical study on the impact of circulating tumor cells on outcomes of urothelial carcinoma of the bladder patients treated with radical cystectomy with or without adjuvant chemotherapyArmin Soave, Sabine Riethdorf, Roland Dahlem, et al.
Journal for Immunotherapy of Cancer|June 16, 2023
First-line treatment of unresectable or metastatic HER2 positive esophagogastric adenocarcinoma: liquid biomarker analysis of the phase 2 INTEGA trialLisa Paschold, Alexander Stein, Benjamin Thiele, et al.
World Journal of Urology|April 24, 2024
Limited prognostic role of routine serum markers (AP, CEA, LDH and NSE) in oligorecurrent prostate cancer patients undergoing PSMA-radioguided surgeryGisa Mehring, Christina Steinbach, Randi Pose, et al.
BJU International|August 26, 2010
Detection of circulating tumour cells in peripheral blood of patients with advanced non-metastatic bladder cancerMichael Rink, Felix K H Chun, Sarah Minner, et al.
Breast Cancer Research : BCR|August 17, 2012
Prognostic impact of circulating tumor cells assessed with the CellSearch System™ and AdnaTest Breast™ in metastatic breast cancer patients: the DETECT studyVolkmar Müller, Sabine Riethdorf, Brigitte Rack, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
Rare expression of epithelial cell adhesion molecule on residual micrometastatic breast cancer cells after adjuvant chemotherapyHolger Thurm, Sebastian Ebel, Christina Kentenich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
Expression of extracellular matrix metalloproteases inducer on micrometastatic and primary mammary carcinoma cellsNatalie Reimers, Kristine Zafrakas, Volker Assmann, et al.
Molecular Oncology|April 24, 2026
Circulating tumor cell viability during and after radiotherapy mirrors treatment response in cancer patientsYvonne Goy, Jana Löptien, Cornelia Coith, et al.
Molecular Oncology|August 6, 2016
Frequent detection of PIK3CA mutations in single circulating tumor cells of patients suffering from HER2-negative metastatic breast cancerChristin Gasch, Theresa Oldopp, Oliver Mauermann, et al.
Clinical Chemistry|May 23, 2013
Capture of viable circulating tumor cells in the liver of colorectal cancer patientsEric Denève, Sabine Riethdorf, Jeanne Ramos, et al.
Pageof 18